ATE264678T1 - Hemmer der angiogenese und der urokinase produktion und seine medizinische anwendung - Google Patents

Hemmer der angiogenese und der urokinase produktion und seine medizinische anwendung

Info

Publication number
ATE264678T1
ATE264678T1 AT99933117T AT99933117T ATE264678T1 AT E264678 T1 ATE264678 T1 AT E264678T1 AT 99933117 T AT99933117 T AT 99933117T AT 99933117 T AT99933117 T AT 99933117T AT E264678 T1 ATE264678 T1 AT E264678T1
Authority
AT
Austria
Prior art keywords
hydrogen atom
angiogenesis
atom
urocinasis
inhibitors
Prior art date
Application number
AT99933117T
Other languages
English (en)
Inventor
Takuma Sasaki
Masatomo Nojima
Original Assignee
Taiho Pharmaceutical Co Ltd
Takuma Sasaki
Masatomo Nojima
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd, Takuma Sasaki, Masatomo Nojima filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE264678T1 publication Critical patent/ATE264678T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99933117T 1998-07-29 1999-07-28 Hemmer der angiogenese und der urokinase produktion und seine medizinische anwendung ATE264678T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23026298 1998-07-29
PCT/JP1999/004030 WO2000006154A1 (fr) 1998-07-29 1999-07-28 Inhibiteurs de la production d'urokinase, inhibiteurs de l'angiogenese et procedes de prevention ou de traitement les utilisant

Publications (1)

Publication Number Publication Date
ATE264678T1 true ATE264678T1 (de) 2004-05-15

Family

ID=16905054

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99933117T ATE264678T1 (de) 1998-07-29 1999-07-28 Hemmer der angiogenese und der urokinase produktion und seine medizinische anwendung

Country Status (5)

Country Link
US (1) US6365610B1 (de)
EP (1) EP1033130B1 (de)
AT (1) ATE264678T1 (de)
DE (1) DE69916571T2 (de)
WO (1) WO2000006154A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4538455B2 (ja) * 2003-07-24 2010-09-08 メルク・シャープ・エンド・ドーム・コーポレイション 抗生物質化合物
EP2087885A1 (de) 2005-06-24 2009-08-12 Wilex AG Verwendung von Urokinasehemmern zur Behandlung und/oder Prävention von neuropathologischen Erkrankungen
EP2083831B1 (de) * 2006-09-22 2013-12-25 Merck Sharp & Dohme Corp. Verfahren zur behandlung von fettsäure-synthese-hemmern
CN104262283B (zh) * 2014-08-19 2017-01-11 北京大学深圳研究生院 1,2-氧氮杂并环类化合物衍生物作为制备治疗骨髓瘤药物的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63122687A (ja) * 1986-11-11 1988-05-26 Kirin Brewery Co Ltd 新規ナフトキノン系化合物ｎｑｙ

Also Published As

Publication number Publication date
US6365610B1 (en) 2002-04-02
EP1033130A1 (de) 2000-09-06
DE69916571T2 (de) 2005-04-07
DE69916571D1 (de) 2004-05-27
WO2000006154A1 (fr) 2000-02-10
EP1033130B1 (de) 2004-04-21
EP1033130A4 (de) 2001-07-25

Similar Documents

Publication Publication Date Title
DK0771794T3 (da) Oxygenholdige heterocykliske forbindelser
NO20034595L (no) Kinolin- og kinazolinderivater med azolylgruppe
ATE139783T1 (de) Azasteroide zur behandlung prostatischer hypertrophie, ihre herstellung und verwendung
NO911231L (no) Fremgangsmaate for fremstilling av 3,5-di-tert. butyl-4-hydroksyfenylmetylen-derivater av 2-substituerte tiazolidinoner, oksazolidinoner og imidazolidinoner.
ATE250573T1 (de) Azetidin- und pyrrolidinderivate
DK0826688T3 (da) Pentacykliske forbindelser
BG104287A (en) Halogensubstituted tetracyclic derivatives of tetrahydrofuran
DE69918695D1 (de) Sauerstoffhaltige heterocyclische verbindungen
PT1044186E (pt) Composto 2-benzilamino-2-fenil-acetamida substituidos
NO971384D0 (no) Pyrimidinylpyrazol-derivat
DE69916571D1 (de) Hemmer der angiogenese und der urokinase produktion und seine medizinische anwendung
DK0806413T3 (da) 2-substituerede viatmin D3-derivater
DE69120603D1 (de) Isochromanderivate
DE60022416D1 (de) Verfahren zur Herstellung von 2-Alkyl-3-aminothiophen Derivate und 3-Aminothiophen Derivate
DK0812835T3 (da) Optisk aktive thiazolidinonderivater
EP0407621A4 (en) Benzothiazole derivatives
NO903514L (no) Imidazolderivat og fremgangsmaate til dets fremstilling.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties